scorecardresearch
Sunday, May 19, 2024
TopicPfizer

Topic: Pfizer

After HCQ, India pushes vaccine diplomacy in S. Asia as China rushes in with its Covid shots

As Beijing offers its own Sinovac-made vaccine to Pakistan, Sri Lanka, Nepal and Bangladesh, India takes steps to have a locally-made vaccine distributed to friendly nations.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

Pfizer Covid shot is highly effective, has no safety concerns, US FDA staff report says

The report offers a first look at the US review of the vaccine ahead of a public meeting Thursday of outside advisers to the agency.

90-year-old Ireland woman becomes first patient to receive Pfizer Covid vaccine

Margaret Keenan became the first person in the world to receive the Pfizer Covid vaccine outside trial conditions after it got the green light in the UK last week.

Govt begins internal review of Pfizer and Serum Covid vaccines, focus on safety & quality

The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.

Pricing of Pfizer’s Covid vaccine will depend on advance booking & doses ordered, says firm

Pfizer has become the first pharmaceutical firm to seek emergency use for its Covid-19 vaccine from the Drugs Controller General of India.

Pfizer seeks emergency use approval of its Covid BioNTech vaccine in India

After the nod from UK and Bahrain, the firm has sought permission to import the vaccine for sale and distribution besides waiver on clinical trials in India.

BioNTech founder Ugur Sahin joins world’s 500 richest after UK approves Covid vaccine

BioNTech’s shares have jumped almost 8% this week and are up more than 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion.

Pfizer, BioNTech seek regulatory clearance from EU for Covid vaccine

BioNTech Chief Financial Officer said the company can start shipping the first doses 'within hours' after regulatory clearance.

Why the above-90% effective Moderna and Pfizer vaccines are truly a breakthrough

The most important challenge for development of an mRNA vaccine remains its inherent instability.

On Camera

Ghatkopar hoarding collapse a typical Mumbai disaster—too many agencies, no one to blame

As per the BMC, there are 1,025 officially approved hoardings in the city right now. However, any Mumbaikar can tell you that number is a ludicrous underestimate.

India’s GDP to grow at 6.9% in 2024 — UN agency revises its January projection of 6.2%

Latest report by UN Department of Economic and Social Affairs says global growth to be faster than estimated earlier & India’s 'robust performance' to boost South Asia’s growth.

Spain denies port call to vessel carrying shipment of ‘arms to Israel from India’

The Spanish foreign minister says 'the Middle East does not need more weapons, it needs more peace'. Spain has been very critical of Israel’s offensive in Gaza.

Abki baar 90 paar for Congress? Why even 30 more seats will ruffle BJP

Discussion about outcome of Lok Sabha polls continues to boil in cauldron of expectations only from BJP. Now reverse this equation, what if we asked about the performance of the 'loser'?